Literature DB >> 22278729

In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.

Klaus Teichmann1, Maxime Kuliberda, Gerd Schatzmayr, Franz Hadacek, Anja Joachim.   

Abstract

Cryptosporidiosis caused by Cryptosporidium spp. is an important diarrhoeal disease observed in farm animals and humans, especially in young or immunocompromised individuals. A novel cell culture assay for testing extracts and pure compounds against Cryptosporidium parvum in 96-well microplate format was established and evaluated. It is based on previously described indirect fluorescent antibody techniques and was optimised for higher sample throughput. Rapid assessment of minimal inhibitory concentrations (MICs) was done by checking each well microscopically for the presence or absence of parasite stages. As a novelty, parasite development was quantified by enumeration of clusters of secondary infection (CSI), which typically appeared upon infection with a distinct parasite inoculum after a defined incubation time. Host cell (HCT-8) viability was measured by an integrated non-destructive water-soluble tetrazolium salt assay (WST-1), which facilitated discrimination of antiparasitic activity from possible cytotoxic effects of a test compound against the host cells. Host cell viability was regarded unimpaired when cultures had 75% or more viability when compared to control cultures without test substance. In this study, a maximum density of distinguishable CSI was obtained when cultures were infected with 2.5 × 10(3) oocysts and incubated for 48 h. The applicable inoculum has to be optimised for each batch of oocysts and before each experimental series. Parasite development was inhibited completely by monensin at 134 nM and silymarin at 50 mg/mL. These concentrations were non-toxic to the host cells and comparable to literature data. The percentages of parasite inhibition were determined for monensin and a 50% inhibitory concentration (IC(50)) of 36.6 nM (27.4-45.5) and a 90% inhibitory concentration of 65.9 nM (54.8-90.2) were calculated. The introduced assay is economic because relatively low parasite numbers may be used. If MICs are determined, evaluation is fast, as each well is viewed only briefly under the fluorescence microscope for presence or absence of CSI. Furthermore it is highly critical because only full parasite inhibition is assessed. Counting of CSI is more laborious and time-consuming, but it allows calculation of parasite inhibition rates and parameters like the half maximal inhibitory concentration (IC(50)). This assay shall be used to assess anticryptosporidial activities of various plant waste materials and by-products from the food and the pharmaceutical industries in the course of the EU project SAFEWASTES. Comparison with in vivo models should be performed to further corroborate the results. Automated evaluation by flow cytometry might facilitate higher sample throughput and reduce operator bias.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278729     DOI: 10.1007/s00436-012-2824-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  46 in total

1.  The development of a real-time quantitative-PCR method for characterisation of a Cryptosporidium parvum in vitro culturing system and assessment of drug efficacy.

Authors:  Louisa M MacDonald; Keith Sargent; Anthony Armson; R C Andrew Thompson; James A Reynoldson
Journal:  Mol Biochem Parasitol       Date:  2002-05       Impact factor: 1.759

2.  Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro.

Authors:  K M Woods; M V Nesterenko; S J Upton
Journal:  Ann Trop Med Parasitol       Date:  1996-12

3.  An in vitro method for detecting infectious Cryptosporidium oocysts with cell culture.

Authors:  T R Slifko; D Friedman; J B Rose; W Jakubowski
Journal:  Appl Environ Microbiol       Date:  1997-09       Impact factor: 4.792

4.  Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro.

Authors:  Xiaomin Cai; Keith M Woods; Steve J Upton; Guan Zhu
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Anti-Giardia activity of phenolic-rich essential oils: effects of Thymbra capitata, Origanum virens, Thymus zygis subsp. sylvestris, and Lippia graveolens on trophozoites growth, viability, adherence, and ultrastructure.

Authors:  Marisa Machado; Augusto M Dinis; Ligia Salgueiro; Carlos Cavaleiro; José B A Custódio; Maria do Céu Sousa
Journal:  Parasitol Res       Date:  2010-03-09       Impact factor: 2.289

6.  Quantitation of Cryptosporidium parvum infection in cell culture using a colorimetric in situ hybridization assay.

Authors:  P A Rochelle; D M Ferguson; A M Johnson; R De Leon
Journal:  J Eukaryot Microbiol       Date:  2001 Sep-Oct       Impact factor: 3.346

7.  In vitro antimalarial activity of medicinal plant extracts against Plasmodium falciparum.

Authors:  Asokan Bagavan; Abdul Abdul Rahuman; Naveen Kumar Kaushik; Dinkar Sahal
Journal:  Parasitol Res       Date:  2010-09-01       Impact factor: 2.289

8.  Combination of cell culture and quantitative PCR for screening of drugs against Cryptosporidium parvum.

Authors:  M Shahiduzzaman; V Dyachenko; A Obwaller; S Unglaube; A Daugschies
Journal:  Vet Parasitol       Date:  2009-03-13       Impact factor: 2.738

9.  An improved in vitro infection model for viability testing of Cryptosporidium parvum oocysts.

Authors:  Michael Najdrowski; Anja Joachim; Arwid Daugschies
Journal:  Vet Parasitol       Date:  2007-10-18       Impact factor: 2.738

10.  Complete development of Cryptosporidium parvum in rabbit chondrocytes (VELI cells).

Authors:  Lizeth Lacharme; Vega Villar; Francisco A Rojo-Vazquez; Susana Suárez
Journal:  Microbes Infect       Date:  2004-05       Impact factor: 2.700

View more
  7 in total

1.  In vitro anthelmintic assessment of selected phytochemicals against Hymenolepis diminuta, a zoonotic tapeworm.

Authors:  Arun K Yadav
Journal:  J Parasit Dis       Date:  2014-09-11

2.  Changes in the levels of Cryspovirus during in vitro development of Cryptosporidium parvum.

Authors:  M C Jenkins; C N O'Brien; M Santin; R Fayer
Journal:  Parasitol Res       Date:  2015-02-24       Impact factor: 2.289

Review 3.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

4.  Assessment of differences between DNA content of cell-cultured and freely suspended oocysts of Cryptosporidium parvum and their suitability as DNA standards in qPCR.

Authors:  Ian D Woolsey; Berit Blomstrand; Øivind Øines; Heidi L Enemark
Journal:  Parasit Vectors       Date:  2019-12-19       Impact factor: 3.876

5.  In vitro inhibitory effects of plant-derived by-products against Cryptosporidium parvum.

Authors:  Klaus Teichmann; Maxime Kuliberda; Gerd Schatzmayr; Thomas Pacher; Karin Zitterl-Eglseer; Anja Joachim; Franz Hadacek
Journal:  Parasite       Date:  2016-09-14       Impact factor: 3.000

6.  Anti-protozoal activity of extracts from chicory (Cichorium intybus) against Cryptosporidium parvum in cell culture.

Authors:  Ian David Woolsey; Angela H Valente; Andrew R Williams; Stig M Thamsborg; Henrik T Simonsen; Heidi L Enemark
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

7.  Extracts of pine bark (Pinus sylvestris) inhibit Cryptosporidium parvum growth in cell culture.

Authors:  Berit Marie Blomstrand; Heidi Larsen Enemark; Øivind Øines; Håvard Steinshamn; Inga Marie Aasen; Karl-Christian Mahnert; Kristin Marie Sørheim; Spiridoula Athanasiadou; Stig Milan Thamsborg; Ian David Woolsey
Journal:  Parasitol Res       Date:  2021-07-16       Impact factor: 2.289

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.